Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 ...
A new Crispr-powered optical blood test detects lung cancer biomarkers at sub-attomolar levels, offering earlier molecular detection than conventional PCR or imaging.
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
Scientists in China say they've built a simple blood test that can spot tell‑tale warning signs of cancer far earlier than a tumour would ever show up on a hospital scanner. The light-based sensor, ...
Blood tests are helpful for monitoring your overall health. But research suggests they can also give us clues about the ...
A new light-based sensor detects cancer markers at near-zero concentrations.
Discover how precision lung cancer care tackles gene fusions, new HER2/ROS1/ALK drugs, expanded screening, and liquid biopsies shaping 2026 treatment.
PALO ALTO, Calif., Dec. 5, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced ...
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and survivorship lung health.
But whether patients should be getting the tests—as some already are—is not yet clear. New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results